The Global Cord Blood Banking Services Market is expected to grow from USD 2.6 billion in 2025 to USD 3.8 billion in 2030, at a CAGR of 8.4%.
Cord blood banking is the process of collecting life-saving stem cells from the umbilical cord and placenta and conserving them for use at a later time. Previously, the blood from the infant's umbilical cord (which ties the baby to the mother while in the womb) was thrown out at delivery, but many parents now save it for their child's future health. Stem cells proliferate in the umbilical cord fluid. Several diseases, including anaemia, cancer, and immune system disorders, affect the capability of the human body to fight itself, and stem cells can be used for their treatment. After the birth, the doctor clips the umbilical cord in two locations, about 10 inches apart, and cuts the cord, separating mother and infant, if the blood is to be kept. Then they inject a needle into the cord and collect at least 40 millilitres of blood. The blood is collected in a bag and transported to a lab or cord blood bank for testing and storage.
The increasing use of stem cell therapies in disease treatment, as well as the increased prevalence of life-threatening genetic abnormalities, are two major market drivers. Furthermore, rising spending power is driving demand for improved healthcare facilities, such as illness prevention and treatment. As a result, parents are increasingly requesting CBB services to safeguard their children's future safety. Furthermore, private players engage in marketing operations aimed at raising awareness of the CBB services' availability and benefits.
Furthermore, governments around the world are supporting public cord blood banks to create ethnically varied cord blood banks, which would boost the odds of finding a good human leukocyte antigen (HLA) match for patients. Such measures are expected to propel the growth of the global cord blood banking services market during the forecast period.
However, the industry's growth is hampered by the high cost and likelihood of non-use, as well as the gynaecologists' recommendation-driven market.
The rising prevalence of blood cancer
The rising occurrence of blood cancer cases is one of the prominent reasons that is anticipated to propel the growth of the global cord blood banking services market during the forecast period. Globally, an estimated 1.2 million instances of blood cancer are recorded each year, with more than 720,000 fatalities. The use of cord blood in the treatment of blood malignancies is becoming more common. Cancers are being treated using stem cell therapies thanks to funding from the government and private groups. Furthermore, rising funding, increased knowledge of stem cell therapies for the treatment of numerous diseases, and increased lymphoma prevalence will all have a beneficial impact on industry demand.
High costs
The market may be slowed by the growing cost of cord blood banking. Private cord blood banking can cost anything from $1,000 to $2,000 in expenses. In addition, a patient must spend $100 to $175 in storage and maintenance fees each year. Furthermore, cord blood banking is not covered or reimbursed by health insurance providers. The high cost of cord blood banking, combined with the lack of insurance coverage, may limit the industry's growth over the predicted period.
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 2.6 billion |
| Total Market Size in 2030 | USD 3.8 billion |
| Forecast Unit | Billion |
| Growth Rate | 8.4% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Bank Type, Service Type, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|